Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1009020170150030243
Clinical Psychopharmacology and Neuroscience
2017 Volume.15 No. 3 p.243 ~ p.247
Improvement of Visuo-spatial Function Assessed by Raven¡¯s Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment
Yoshino Yuta

Mori Takaaki
Yoshida Taku
Toyota Yasutaka
Shimizu Hideaki
Iga Junichi
Nishitani Shusaku
Ueno Shuichi
Abstract
Objective: Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven¡¯s Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil.

Methods: Twenty-one DLB patients (mean age, 78.7¡¾4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil.

Results: There were significant improvements of RCPM in the total scores between one year donepezil treatment (p=0.013), in both Set A score (p=0.002) and Set AB score (p=0.015), but trend in the Set B score (p=0.083).

Conclusion: Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment.
KEYWORD
Lewy body dementia, Cholinesterase inhibitors, Raven¡¯s Colored Progressive Matrices, Visual spatial processing
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed